Centro de Investigacion Biomedica en Red de Salud Mental-ko ikertzaileekin lankidetzan egindako argitalpenak (11)

2022

  1. A functional neuroimaging association study on the interplay between two schizophrenia genome-wide associated genes (CACNA1C and ZNF804A)

    European Archives of Psychiatry and Clinical Neuroscience, Vol. 272, Núm. 7, pp. 1229-1239

2021

  1. Chronic obstructive pulmonary disease in severe mental illness: A timely diagnosis to advance the process of quitting smoking

    European psychiatry : the journal of the Association of European Psychiatrists, Vol. 64, Núm. 1, pp. e22

2019

  1. Pattern of use of clozapine in Spain. Variability and under-prescription

    Revista de Psiquiatria y Salud Mental, Vol. 12, Núm. 3, pp. 151-162

2018

  1. Deficit of entropy modulation of the EEG in schizophrenia associated to cognitive performance and symptoms. A replication study

    Schizophrenia Research, Vol. 195, pp. 334-342

2017

  1. Functional EEG network analysis in schizophrenia: Evidence of larger segregation and deficit of modulation

    Progress in Neuro-Psychopharmacology and Biological Psychiatry, Vol. 76, pp. 116-123

2016

  1. Elevated midline-parietal gamma band noise power in schizophrenia but not in bipolar patients

    European Archives of Psychiatry and Clinical Neuroscience, Vol. 266, Núm. 8, pp. 743-753

  2. Identification of two clusters within schizophrenia with different structural, functional and clinical characteristics

    Progress in Neuro-Psychopharmacology and Biological Psychiatry, Vol. 64, pp. 79-86

2014

  1. Greater clinical and cognitive improvement with clozapine and risperidone associated with a thinner cortex at baseline in first-episode schizophrenia

    Schizophrenia Research, Vol. 158, Núm. 1-3, pp. 223-229

2013

  1. Randomized trial of clozapine vs. risperidone in treatment-naïve first-episode schizophrenia: Results after one year

    Schizophrenia Research, Vol. 149, Núm. 1-3, pp. 156-161

2011

  1. Convergent evidence of the contribution of TP53 genetic variation (Pro72Arg) to metabolic activity and white matter volume in the frontal lobe in schizophrenia patients

    NeuroImage, Vol. 56, Núm. 1, pp. 45-51

2008

  1. A 12-month, open-label, comparative study of quetiapine and risperidone in the acute and long-term treatment of schizophrenia

    International Clinical Psychopharmacology, Vol. 23, Núm. 3, pp. 138-149